STOCK TITAN

OneMedNet (NASDAQ: ONMD) moves 2026 annual meeting to September 18

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

OneMedNet Corporation has set September 18, 2026 as the date of its 2026 Annual Meeting of Stockholders, with August 11, 2026 as the record date for stockholders entitled to notice of and to vote at the meeting.

Stockholder proposals for inclusion in the company’s proxy materials, other stockholder proposals, and nominations of director candidates must all be received by the Secretary of the company no later than August 5, 2026, in accordance with SEC Rule 14a-8, SEC Rule 14a-19 for any director election contest, and the company’s Bylaws.

Positive

  • None.

Negative

  • None.
Item 5.08 Shareholder Director Nominations Governance
Shareholder nominations for board of directors under proxy access rules. Rarely used -- the underlying SEC rule was vacated.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
2026 Annual Meeting date September 18, 2026 Date of the 2026 Annual Meeting of Stockholders
Record date August 11, 2026 Record date for stockholders entitled to notice of and to vote at the 2026 Annual Meeting
Proposal and nomination deadline August 5, 2026 Deadline for stockholder proposals, director nominations, and Rule 14a-19 proxy contest notices for the 2026 Annual Meeting
Rule 14a-8 regulatory
"pursuant to SEC Rule 14a-8 under the Securities Exchange Act of 1934"
Rule 14a-8 is a U.S. Securities and Exchange Commission regulation that lets eligible shareholders put proposals on a public company’s proxy ballot for an annual meeting, provided they meet basic ownership and filing requirements. It matters to investors because it creates a formal way to raise governance or strategic issues and force a company-wide vote—like getting an item onto the agenda of a neighborhood association meeting once you’ve lived there long enough—so shareholders can push for change or influence management decisions.
Rule 14a-19 regulatory
"Additionally, pursuant to SEC Rule 14a-19, a stockholder intending to engage"
Rule 14a-19 is a U.S. Securities and Exchange Commission rule that governs how independent proxy advisory firms produce and distribute voting recommendations for shareholders. It requires these advisers to provide companies with notice of their recommendations and a chance to respond, and to disclose certain conflicts; think of it as a referee ensuring both sides see a game plan before fans cast votes. Investors care because proxy advisers influence voting outcomes and corporate governance, so the rule affects transparency, potential bias, and the reliability of guidance that many investors rely on when voting shares.
record date financial
"The record date for stockholders entitled to notice of and to vote"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
proxy materials regulatory
"to be eligible for inclusion in the Company’s proxy materials relating to"
Proxy materials are the packet of documents sent to shareholders that explain items to be voted on at a company meeting and include the actual ballot or instructions for casting a vote. Think of them as a voting packet that lays out who’s running the company, major proposals (like pay, mergers, or board changes), and arguments for and against each item. Investors care because those votes shape corporate direction, affect risk and future profits, and can influence share value.
director election contest regulatory
"a stockholder intending to engage in a director election contest with respect"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

When is OneMedNet (ONMD) holding its 2026 Annual Meeting of Stockholders?

OneMedNet plans to hold its 2026 Annual Meeting of Stockholders on September 18, 2026. The meeting date was set by the Board of Directors and differs by more than 30 days from the 2025 meeting date of December 17, 2025.

What is the record date for voting at OneMedNet (ONMD)’s 2026 Annual Meeting?

The record date for stockholders entitled to notice of and to vote at OneMedNet’s 2026 Annual Meeting is August 11, 2026. Only stockholders of record at the close of business on that date will be eligible to vote.

What is the deadline for OneMedNet (ONMD) stockholder proposals for the 2026 meeting?

Stockholder proposals intended for inclusion in OneMedNet’s proxy materials for the 2026 Annual Meeting must be received by the Secretary no later than August 5, 2026. Proposals must also meet all requirements of SEC Rule 14a-8 and the company’s Bylaws.

When must OneMedNet (ONMD) stockholders submit director nominations for the 2026 meeting?

All stockholder nominations of candidates for election as directors at OneMedNet’s 2026 Annual Meeting must be received by the Secretary by August 5, 2026. Nominations must comply with the company’s Bylaws and other applicable legal requirements.

What are the requirements for a director election contest at OneMedNet (ONMD)’s 2026 meeting?

A stockholder intending to engage in a director election contest at the 2026 Annual Meeting must give notice under SEC Rule 14a-19 by August 5, 2026, providing the nominee name(s) and other specified information to the company.

Where should OneMedNet (ONMD) stockholders send proposals or nominations for the 2026 Annual Meeting?

Proposals, director nominations, and notices of intent to solicit proxies for the 2026 Annual Meeting should be mailed or delivered to OneMedNet Corporation, 6385 Old Shady Oak Road, Suite 250, Eden Prairie, Minnesota 55344, Attention: Secretary.
false 0001849380 0001849380 2026-07-24 2026-07-24 0001849380 ONMD:CommonStock0.0001ParValuePerShareMember 2026-07-24 2026-07-24 0001849380 ONMD:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2026-07-24 2026-07-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 24, 2026

 

 

 

ONEMEDNET CORPORATION

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-40386   86-2076743

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

6385 Old Shady Oak Road, Suite 250

Eden Prairie, MN 55344

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 800-918-7189

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.0001 par value per share   ONMD   The Nasdaq Stock Market LLC
         
Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share   ONMDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.08 Shareholder Director Nominations.

 

To the extent applicable, the information set forth below under Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.

 

Item 8.01 Other Events.

 

The Board of Directors of OneMedNet Corporation (the “Company”) has established September 18, 2026 as the date of the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). The record date for stockholders entitled to notice of and to vote at the 2026 Annual Meeting will be August 11, 2026. Additional details regarding the 2026 Annual Meeting, including the matters to be considered and voted upon at the 2026 Annual Meeting, will be set forth in the Company’s definitive proxy statement for the 2026 Annual Meeting to be filed with the Securities and Exchange Commission (the “SEC”).

 

Because the 2026 Annual Meeting date has been changed by more than 30 calendar days from the anniversary date of the 2025 annual meeting held on December 17, 2025 (the “2025 Annual Meeting”), pursuant to SEC Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and the Bylaws of the Company (the “Bylaws”), the deadlines for stockholder nominations and proposals for consideration at the 2026 Annual Meeting set forth in the Company’s 2025 Annual Meeting proxy statement have been updated as set forth herein.

 

Proposals by stockholders intended to be presented at the 2026 Annual Meeting must be received by the Secretary of the Company no later than August 5, 2026, to be eligible for inclusion in the Company’s proxy materials relating to the 2026 Annual Meeting. The Company has determined that this date is a reasonable time before it expects to begin to print and send its proxy materials for the 2026 Annual Meeting in accordance with Rule 14a-8(e). The Company will not be required to include in its proxy, notice of meeting or proxy statement a stockholder proposal that is received after that date or that otherwise fails to meet the requirements for stockholder proposals established by applicable SEC rules and the Bylaws. Any stockholder who intends to submit a proposal other than for inclusion in the Company’s proxy materials for the 2026 Annual Meeting must deliver such proposal to the Secretary of the Company no later than August 5, 2026.

 

Any proposals by stockholders intended to be presented at the 2026 Annual Meeting, and any notices of intent to solicit proxies for the 2026 Annual Meeting, should be mailed or delivered to OneMedNet Corporation, 6385 Old Shady Oak Road, Suite 250, Eden Prairie, Minnesota 55344, Attention: Secretary. Such proposals must also comply with all other requirements set forth in the Bylaws and other applicable laws.

 

As set forth in the 2025 Annual Meeting proxy statement and as provided in the Bylaws, all stockholder nominations of candidates for election as directors of the Company must be received by the Secretary of the Company no later than August 5, 2026. Additionally, pursuant to SEC Rule 14a-19, a stockholder intending to engage in a director election contest with respect to the 2026 Annual Meeting must give the Company notice of its intent to solicit proxies by providing the name(s) of the stockholder’s nominee(s) and certain other information by August 5, 2026. All stockholder nominations must be made in writing and delivered or mailed to the Secretary of the Company at the Company’s principal executive offices located at 6385 Old Shady Oak Road, Suite 250, Eden Prairie, Minnesota 55344.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 24, 2026

 

  ONEMEDNET CORPORATION
     
  By: /s/ Aaron Green
    Aaron Green
    Chief Executive Officer

 

 

 

Filing Exhibits & Attachments

4 documents